Company news

Renalytix PLC news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Thomas McLain Appointed as President and CCO

July 29, 2019

Result of Placing & Total Voting Rights

July 23, 2019

US Exec Order on Advancing American Kidney Health

July 12, 2019

Positive Interim Results for Validation Study

July 9, 2019

FractalDx Positive Results Published in JASN

July 8, 2019

US CPT® Code Granted for KidneyIntelX(TM)

July 1, 2019

Positive results from FractalDx study published

June 7, 2019

KidneyIntelX commercial scale production milestone

June 4, 2019

CLIA Certificate Number issued for Renalytix Lab

May 28, 2019

Expansion of FractalDx core investigator group

May 21, 2019

University Medical Center Groningen collaboration

May 7, 2019

FDA grants Breakthrough Device designation

May 2, 2019

Publication of confirmation study results

April 1, 2019

RenalytixAI Forms Core Investigator Group

March 22, 2019

Investor briefing

March 12, 2019

Appointment of Nomad and Joint Broker

February 14, 2019

Joint venture partnership agreement with AKESOgen

February 13, 2019

RenalytixAI Expands Leadership Team

February 6, 2019

Initiates Clinical Validation Study

January 23, 2019

Clarification re. lock-up restrictions

January 21, 2019

Exercise of Option for Exclusive License

January 2, 2019

Planned appointment of joint broker & of NOMAD

December 20, 2018

Director Dealing

December 19, 2018

RENX Admission to AIM and First Day of Dealings

November 6, 2018

← Newer news releases

Calls

The 5 newest of 17 calls. Every call is listed under its year.

Decks